This $358,000 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a 2-year study by Brigham & Women's Hospital to characterize and address the problem of nonresponse in the collection of patient-reported outcome (PRO) data in routine cancer care.
The study aims to: 1) analyze nonresponse patterns in PRO data collected across multiple radiation oncology clinics, 2) identify multilevel factors contributing to nonresponse, and 3) develop methods to enhance the representativeness of existing PRO data. The research seeks to generate generalizable strategies to improve the reach and completeness of PRO data collection, which is critical for leveraging this information to enhance patient-centered cancer care, quality improvement, and value-based healthcare. The award period runs from August 1, 2024 through July 31, 2026.
Generated 1/28/25, 10:37 AM